5-MeO-DMT cuts heavy drinking by 77% in alcohol disorder trial — while childhood trauma predicts psychedelic difficulties

Key Findings

🧠 Childhood trauma doubles risk of psychedelic difficulties

• Among 3,168 U.S. adults with lifetime psychedelic use, 6.4% reported difficulties lasting more than one day, while 1.3% had problems persisting over a year

• People with 4+ adverse childhood experiences had 2.84 times higher odds of psychedelic-related difficulties compared to those with no childhood trauma

• The most common persistent problems were general anxiety (33.9%), negative changes in self-concept (25.9%), and social disconnection (23%)

🔬 Psilocybin rewires brain's reward system in mice

• Brain imaging in 11 healthy participants showed psilocybin decreased connectivity between the nucleus accumbens (reward center) and ventral tegmental area—a pathway often overactive in addiction

• The psychedelic also increased connections between reward regions and the anterior cingulate cortex, an area involved in decision-making

• Changes correlated with alterations in perception and volition, as measured by hallucination rating scales

📊 Psychedelic research excludes communities most in need

• Analysis of 27 U.S. clinical trials with psilocybin, MDMA, and LSD over the past decade found only 3 studies (11%) used community-engaged research practices

• People of color remain significantly underrepresented in psychedelic trials despite facing conditions commonly treated with these therapies

• When community engagement was used, researchers only employed basic consultation rather than deeper collaborative approaches

🎯 Mystical experiences predict therapy success—but not always

• Systematic review of 54 studies found that intense mystical-type experiences during psychedelic sessions were the most frequent predictor of therapeutic benefit

• However, this pattern wasn't consistent across all mental health conditions or follow-up timepoints

• Factors related to mindset, setting, and dose were frequently linked to the likelihood of having mystical experiences

🧪 LSD microdosing improves depression through interconnected changes

• 17 people with major depression took LSD microdoses twice weekly for 8 weeks, then described their experiences in detailed interviews

• Participants reported enhanced self-determination, increased social connection, improved thinking patterns, and better emotional well-being

• These effects appeared to reinforce each other in a positive cycle, though not everyone improved and some experienced side effects

💊 AI platform predicts ketamine response with 95% accuracy

• NetraAI analyzed psychiatric scales and brain imaging data from 63 people in a ketamine depression trial, identifying key predictive features

• The AI achieved 95% accuracy using just 8 brain imaging features and 100% specificity in detecting treatment responders

• This outperformed traditional machine learning by 25-30% and could help identify which patients are most likely to benefit before treatment